Scimitar Equity Research Issues Review of Physiometrix, Inc.

Scimitar Equity Research Issues Review of Physiometrix, Inc.



BOSTON, March 8  /PRNewswire-FirstCall/ -- Scimitar Equity Research, Inc.
issues a review of Physiometrix, Inc. (NASDAQ:PHYX), entitled, "The Shape of
Things to Come".  This review is available at our website:
http://www.scimitarequity.com/.

Scimitar Equity Research, Inc. (Scimitar) provides sponsored equity research of
the health sciences industry for the institutional and investment communities. 
We certify that all the views expressed in this review, accurately reflect our
personal views about PHYX (NASDAQ) and its or their securities.  No part of our
compensation was, is, or will be, directly or indirectly, related to the
specific recommendations or views contained in this review and we will not have
any investment banking relationships or personal investment in any sponsored
company.  Investors are advised that this analysis and review is issued solely
for informational purposes and is not to be construed as an offer to sell or
the solicitation of an offer to buy. Scimitar was paid for preparing this
review.  This analysis and review does not have regard to the specific
investment objectives, financial situation and the information contained herein
is based on sources that we believe to be reliable but is not guaranteed by us
as being accurate and does not purport to be a complete statement or summary of
the available data.  Any opinions expressed are statements of our own judgment
as of the date of publication and are subject to change without notice.  Please
read all our important disclosures.

  CONTACT:
   Scimitar Equity Research, Inc.
   Henry W. McCusker
   Director of Research
   phone: [phone]
   fax: [phone]
   e-mail: 

DATASOURCE: Scimitar Equity Research



CONTACT:  Henry W. McCusker, Director of Research of Scimitar Equity

Research, Inc., [phone], 



Web site:  http://www.scimitarequity.com/

Copyright